Van Heukelom, Joel <br/><br/>
Dabigatran and bleeding: still an emergent situation?  [electronic resource] 

 -  The American journal of the medical sciences  Sep 2013 
 - 259 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1538-2990 
<br/><br/><label>Standard No.: </label>10.1097/MAJ.0b013e3182960987  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antithrombins--adverse effects<br/>Benzimidazoles--adverse effects<br/>Coagulants--therapeutic use<br/>Dabigatran<br/>Factor VIII--therapeutic use<br/>Factor VIIa--therapeutic use<br/>Hemorrhage--chemically induced<br/>Humans<br/>Prothrombin--therapeutic use<br/>Recombinant Proteins--therapeutic use<br/>Renal Dialysis<br/>beta-Alanine--adverse effects